Affordable Access

Publisher Website

Transferrin C2 variant does not confer a risk for Alzheimer's disease in Koreans

Authors
Journal
Neuroscience Letters
0304-3940
Publisher
Elsevier
Publication Date
Volume
308
Issue
1
Identifiers
DOI: 10.1016/s0304-3940(01)01985-1
Keywords
  • Alzheimer'S Disease
  • Risk
  • Transferrin
  • Apolipoprotein E
  • Age-At-Onset
  • Koreans
Disciplines
  • Biology
  • Medicine

Abstract

Abstract We analyzed the transferrin (TF) and apolipoprotein E (APOE) genotypes of 164 probable Alzheimer's disease (AD) patients and 239 cognitively normal elderly controls in Koreans. We failed to detect a significant difference in genotypic frequencies and allelic frequencies of the TF polymorphism between the AD group and control group ( P>0.1 by Chi square test). The frequency of the TF C2 variant did not differ by the diagnosis when the APOE ε4-positive subjects and APOE ε4-negative subjects were analyzed separately ( P>0.1 by Chi square test). The TF C2 variant did not influence the age-at-onset of AD independently or synergistically with the occurrence of the APOE ε4 allele ( P>0.1 by ANOVA). The TF C2 variant did not confer a risk for AD in Koreans.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Transferrin C2 variant does not confer a risk for...

on Neuroscience Letters Jul 27, 2001

Neither the butyrylcholinesterase K variant nor tr...

on Journal of neural transmission... 2001

Transferrin C2 variant does confer a risk for Alzh...

on Journal of Alzheimer s Disease December 2003

Transferrin C2 allele, haemochromatosis gene mutat...

on Journal of Neurology Neurosurg... June 2002
More articles like this..